First Republic Investment Management, Inc. Blueprint Medicines Corp Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 4,040 shares of BPMC stock, worth $373,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,040

Previous 3,963 1.94%

Holding current value

$373,457

Previous $250,000 19.2%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$46.9 - $66.0 $3,611 - $5,082	77 Added 1.94%	4,040 $202,000
Q2 2023 Jul 28, 2023	BUY	$42.2 - $66.37 $167,238 - $263,024	3,963 New	3,963 $250,000
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $1,108 - $1,794	-27 Reduced 0.56%	4,831 $211,000
Q3 2022 Nov 03, 2022	SELL	$49.93 - $77.7 $4,144 - $6,449	-83 Reduced 1.68%	4,858 $320,000
Q2 2022 Aug 16, 2022	SELL	$45.23 - $70.15 $4,070 - $6,313	-90 Reduced 1.79%	4,941 $250,000
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $3,137 - $6,384	58 Added 1.17%	5,031 $321,000
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $485 - $656	6 Added 0.12%	4,973 $511,000
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $496 - $606	6 Added 0.12%	4,967 $437,000
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $22,496 - $26,853	-248 Reduced 4.76%	4,961 $482,000
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $3,775 - $5,103	41 Added 0.79%	5,209 $584,000
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $71,500 - $99,745	1,076 Added 26.3%	5,168 $479,000
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $481 - $822	-10 Reduced 0.24%	4,092 $239,000
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $667 - $825	10 Added 0.24%	4,102 $329,000
Q2 2019 Aug 07, 2019	SELL	$73.54 - $97.8 $147,080 - $195,600	-2,000 Reduced 32.83%	4,092 $386,000
Q1 2019 Apr 30, 2019	BUY	$48.7 - $86.6 $103,195 - $183,505	2,119 Added 53.34%	6,092 $488,000
Q4 2018 Feb 12, 2019	SELL	$45.57 - $74.26 $10,435 - $17,005	-229 Reduced 5.45%	3,973 $214,000
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $11,605 - $15,429	197 Added 4.92%	4,202 $328,000
Q4 2017 Feb 09, 2018	SELL	$62.91 - $88.32 $12,330 - $17,310	-196 Reduced 4.67%	4,005 $302,000
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $177,996 - $292,683	4,201	4,201 $293,000

Others Institutions Holding BPMC

# of Institutions

340

Shares Held

62M

Call Options Held

987K

Put Options Held

578K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.52B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Blueprint Medicines Corp Transaction History